Hybio Pharmaceutical Co., Ltd. (SHE:300199)
China · Delayed Price · Currency is CNY 22.12
+1.06 (5.03%)
Nov 3, 2025, 2:45 PM CST
Hybio Pharmaceutical Market Cap
Hybio Pharmaceutical has a market cap or net worth of 18.6 billion as of November 3, 2025. Its market cap has increased by 76.23% in one year.
Market Cap
18.60B
Enterprise Value
20.40B
Revenue
898.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.12
Market Cap Chart
Since April 7, 2011, Hybio Pharmaceutical's market cap has increased from 2.93B to 18.60B, an increase of 534.85%. That is a compound annual growth rate of 13.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 18.60B | 63.38% |
| Dec 31, 2024 | 11.38B | -5.08% |
| Dec 29, 2023 | 11.99B | -22.75% |
| Dec 30, 2022 | 15.53B | 39.41% |
| Dec 31, 2021 | 11.14B | 88.22% |
| Dec 31, 2020 | 5.92B | 14.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 421.16B |
| WuXi AppTec | 284.99B |
| Shenzhen Mindray Bio-Medical Electronics | 260.07B |
| Sichuan Biokin Pharmaceutical | 157.69B |
| Shanghai United Imaging Healthcare | 114.74B |
| Aier Eye Hospital Group | 113.87B |
| Zhangzhou Pientzehuang Pharmaceutical., | 107.81B |
| Yunnan Baiyao Group Co.,Ltd | 101.10B |